NCT01724476View on ClinicalTrials.gov

A Trial of Folate With B12 in Patients With Schizophrenia With Residual Symptoms in Ethiopia

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

December 31, 2017

Conditions
Schizophrenia
Interventions
DRUG

folate with B12

DRUG

placebo

Trial Locations (1)

Unknown

Amanuel Mental Hospital, Addis Ababa

All Listed Sponsors
collaborator

Addis Ababa University

OTHER

collaborator

Amanuel Mental Hospital, Addis Ababa, Ethiopia

UNKNOWN

lead

Massachusetts General Hospital

OTHER

NCT01724476 - A Trial of Folate With B12 in Patients With Schizophrenia With Residual Symptoms in Ethiopia | Biotech Hunter | Biotech Hunter